AKOUOS Logo (EUIPO, 05/12/2021)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark AKOUOS was filed as Figurative mark on 05/12/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/11/2022.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#One line or one band #Wavy lines or bands, zigzag lines or bands #Letters crossed or barred by letters, numerals or a figurative element
| Trademark form | Figurative mark |
| File reference | 018471143 |
| Application date | May 12, 2021 |
| Publication date | October 4, 2021 |
| Entry date | January 11, 2022 |
| Expiration date | May 12, 2031 |
Trademark owner
645 Summer Street, Suite 200
02210 Boston
US
02210 Boston
US
Trademark representatives
2 Grand Canal Square
2 Dublin
IE
goods and services
5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
10
Drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
41
Providing a website in relation to education information regarding inner ear disorders and conditions, hearing loss and genetics
42
Scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 17, 2021 | Transfer / Change of address, Registered |
ID: 11018471143